This inventor holds 2 USPTO granted patents. Top assignees: Gse-Forschungszentrum Fur Umwelt Und Gesundheit Gmbh, Gsf-Forschungszentrum Fur Umwelt Und Gesundheit, Gmbh. Active years: 2006-2009.
Company Filing History:
Years Active: 2006-2009
Title: Konrad Maier: Innovator in Tracheo-Bronchial Treatments
Introduction
Konrad Maier is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical treatments, particularly focusing on illnesses affecting the tracheo-bronchial tract. With a total of 2 patents, his work has the potential to impact the lives of many suffering from chronic respiratory conditions.
Latest Patents
Maier's latest patents include innovative methods for treating illnesses of the tracheo-bronchial tract, especially chronic obstructive pulmonary disease (COPD). The first patent describes a means for the treatment of diseases affecting this area, specifically targeting COPD. The second patent also focuses on an agent for treating illnesses of the tracheobronchial tract, again with a particular emphasis on COPD. These inventions highlight his commitment to advancing medical treatments in respiratory health.
Career Highlights
Throughout his career, Konrad Maier has worked with esteemed organizations such as the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH. His experience in these research institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.
Collaborations
Maier has collaborated with notable professionals in his field, including Marion Frankenberger and Gerhard Scheuch. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Konrad Maier's contributions to the treatment of tracheo-bronchial illnesses, particularly COPD, underscore his role as a significant inventor in the medical field. His patents reflect a dedication to improving respiratory health and enhancing the quality of life for patients.